BIAF
Closed
Bioaffinity Technologies Inc.
0.263
-0.024 (-8.36%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.2872
Day's Range: 0.255 - 0.289
Send
sign up or login to leave a comment!
When Written:
1.89
BioAffinity Technologies Inc. is a biotechnology company that develops and commercializes proprietary technologies for the early detection and targeted treatment of cancer. The company's flagship product is the CyPath Lung test, a non-invasive diagnostic test that detects early-stage lung cancer by analyzing sputum samples. BioAffinity Technologies also develops targeted cancer therapies based on its proprietary platform technology, which uses a unique class of molecules called Affinity Peptides to selectively target cancer cells while sparing healthy cells. The company is headquartered in San Antonio, Texas, and is publicly traded on the OTCQB under the ticker symbol "BIOAF."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








